EPTB Diagnostics
Cross-source consensus on EPTB Diagnostics from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Benefits
Evidence quality
Highlighted claims
- Current diagnostic tools for EPTB can have suboptimal accuracy. — Economic evidence of health technology innovations for the diagnosis of extrapulmonary TB in resource-limited settings: a scoping review protocol
- Xpert Ultra and adenosine deaminase testing may have low sensitivity or inconsistent performance depending on EPTB disease site. — Economic evidence of health technology innovations for the diagnosis of extrapulmonary TB in resource-limited settings: a scoping review protocol
- IRISA-TB is identified as a future target for economic evaluation among emerging diagnostic tools. — Economic evidence of health technology innovations for the diagnosis of extrapulmonary TB in resource-limited settings: a scoping review protocol
- Emerging diagnostic technologies such as interferon-gamma-based assays may detect EPTB faster and more accurately. — Economic evidence of health technology innovations for the diagnosis of extrapulmonary TB in resource-limited settings: a scoping review protocol